Latest News and Press Releases

DUNMORE, Pa., May 06, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC), parent company of The Fidelity Deposit and Discount Bank, announce their...

— Repurchased $190 Million of Shares— — Reaffirms Full Year Outlook — KANSAS CITY, Mo., Feb. 04, 2025 (GLOBE NEWSWIRE) -- H&R Block, Inc. (NYSE: HRB) (the "Company") today released...

KANSAS CITY, Mo., Jan. 21, 2025 (GLOBE NEWSWIRE) -- H&R Block, Inc. (NYSE: HRB) will report fiscal 2025 second quarter results on Tuesday, February 4, 2025, after the New York Stock Exchange...

Revenues of INR 10275 Million. EBITDA of INR 1963 Million. Profit for the period INR 49 Million. CHENNAI, India, Oct. 22, 2024 (GLOBE NEWSWIRE) -- EARNINGS CALL DETAILS  October, 22, 2024 |...

MoonLake Immunotherapeutics to host a Capital Markets Updateon Wednesday, September 11ZUG, Switzerland, September 9, 2024 – MoonLake Immunotherapeutics AG (“MoonLake”; Nasdaq: MLTX), a clinical-stage...

GDEV announces unaudited results for the second quarter and first half of 2024

COPENHAGEN, Denmark, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines,...

~ Delivers Sequential Revenue Growth of 27% to $22.5 Million ~ ~ Introduces New KPI, Average Revenue Per User (ARPU), Up 19% Over First Quarter ~ LONGBOAT KEY, Fla., Aug. 12, 2024 (GLOBE...

COPENHAGEN, Denmark, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Aug. 08, 2024 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or...